Braingaze was originally founded as a spin-off company from the University of Barcelona in 2013, being now globally based with offices in both Barcelona, Spain and Surrey, UK. We provide BGaze Clinic, a reliable solution for the diagnosis, treatment and monitoring of cognitive disorders by using eye-movement and biomarker analysis techniques.
Current diagnostic methods are often time-consuming, expensive and do not leverage the potential added value of digital tools. Braingaze aims to transform healthcare systems by integrating digital tools that offer a cost-effective, objective, and engaging patient journey.
Laszlo Bax
Co-founder and CEO
Hans Supèr
Co-founder and CTO
Antonio Borrero
Lead Software Developer
Chandanee Mistry
UK Commercial Lead
Jordi Espada
Software Developer
Chamith Ranathunga
Lead AI Engineer
Hannah Lawton
Research and Clinical Officer
Nicolás Perea
Regulatory Lead
Braingaze Spain, Avinguda Ernest Lluch 32, Tecnocampus, 08302 Mataro (Barcelona) Spain
Braingaze UK, 157 High Street, New Malden (Greater London) KT3 4BH United Kingdom
Our Partners
Braingaze in the Media
New innovative health technology fund aims to invest with impact
A new health innovation fund is investing in health and care technologies and innovations to transform the current health and social care system, including improving access to and quality of care. The Special Opportunities Fund is starting with Braingaze, a revolutionary new tool that uses eye tracking to help diagnose ADHD in a matter of minutes. The tool enables drug-free cognitive disorders treatment and brings brain-related healthcare into the digital and AI-powered age.
March 7th, 2024 by Charity Today.
DTx Consortium and Vodafone Business will drive the adoption of digital therapies in Spain
The DTx Consortium and Vodafone Business will collaborate to promote the use of digital therapies in Spain. This agreement aims to promote access to innovative digital treatments to improve the health of the population. Vodafone Business will provide its infrastructure and technology to support the implementation and distribution of these therapies, thus facilitating their adoption nationwide.
May 18th, 2023 by Portaltic.
China Daily
3 Jul. 2020
Deal Street Asia
3 Jul. 2020
Mobi Health News
2 Jun. 2020
Business Cloud
17 Oct. 2016
CNET
16 Mar. 2016
BBC Radio live In Short
13 Oct. 2016
Parent Herald
17 Oct. 2016
El Referente
9 Aug. 2016
Emprendedores.es
15 Sep. 2016
Expansió
3 Jun. 2016
Ara
30 Apr. 2016
Diario Médico
31 Mar. 2016
Emprendedores.es
18 Jan. 2016
© 2024. Braingaze. All Rights Reserved. Contact: info@braingaze.com Phone: +34 93 169 65 72
